Bioactive glass S53P4 and autograft bone in treatment of depressed tibial plateau fractures: A prospective randomized 11-year follow-up

Journal of Long-Term Effects of Medical Implants

Volumn 21, Issue 2, 2011, Pages 139-148

  Pernaa, K ^a   Koski, I ^a   Mattila, K ^a   Gullichsen, E ^a   Heikkila J ^a   Aho, A J ^a   Lindfors, N C ^b  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Bioactive glass; Bone substitute; Tibial plateau fracture

Indexed keywords

BONE; COMPUTERIZED TOMOGRAPHY; FRACTURE;

ARTICULAR SURFACES; BONE GRAFT SUBSTITUTES; BONE SUBSTITUTES; COMPUTED TOMOGRAPHY SCAN; FOLLOW-UP STUDIES; LONG-TERM FOLLOW-UP; LONG-TERM RESULTS; TIBIAL PLATEAU;

BIOACTIVE GLASS;

BIOACTIVE GLASS; GLASS; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOGRAFT; BIOMECHANICS; BONE GRAFT; BONE PROSTHESIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; MALE; OSTEOARTHRITIS; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; RADIODIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; SURFACE PROPERTY; TIBIA FRACTURE;

EID: 80055061035     PISSN: 10506934     EISSN: None     Source Type: Journal    
DOI: 10.1615/JLongTermEffMedImplants.v21.i2.40     Document Type: Article

References (27)

1. Hench LL, Paschall HA. Direct chemical bond of bioactive glass-ceramic materials to bone and muscle. J Biomed Mater Res Symp 1973;4: 25-42.
2. Hench LL, Wilson J. Surface active biomaterials. Science 1984;226:630-35.
3. Hench LL. Bioactive ceramics. Annales of N Y Academy Science 1988;523:54-71.
4. Andersson ÖH, Karlsson KH, Kangasniemi K. Calcium phosphate formation at the surface of bioactive glass in vivo. J Non-Crystal Solids 1990;119:290-6.
5. Andersson ÖH, Kangasniemi I. Calcium phosphate formation at the surface of bioactive glass in vitro. J Biomed Mater Res 1991;24:1019-30.
6. Leppäranta O, Vaahtio M, Peltola T, Zhang D, Hupa L, Hupa M, Ylänen H, Salonen JI, Viljanen MK, Eerola E., Antibacterial effect of bioactive glasses on clinically important anaerobic bacteria in vitro. J Mater Sci: Mater Med 2008;19:547-51.
7. Munukka E, Leppäranta O, Korkeamäki M, Vaahto M, Peltola T, Zhang D, Hupa L, Ylänen H, Peltola MJ, Aitasalo KMJ, Suonpää JTK, Yli-Urpo A, Laippala PJ. In vivo model for frontal sinus and calvarian bone defect obliteration with bioactive glass S53P4 and hydroxyapatite. J Biomed Mater Res Appl Biomater 2001;58:261-9.
8. Lindfors NC, Hyvönen P, Nyyssönen MM, Kirjavainen M, Kankare, Gullichsen E, Salo J., Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis. Bone 2010;47:212-8.
9. Virolainen P, Heikkilä J, Yli-Urpo AA, Vuorio E, Aro HT., Histomorphometric and molecular biologic comparison of bioactive glass granules and autogenous bone grafts in augmentation of bone healing. J Biomed Mater Res 1997;35:9-17.
10. Folkman J. Tumor angiogenesis. Adv Cancer Res 1985;43:175-203.
11. Day RM. Bioactive glass stimulates the secretion of angiogenetic growth factors and angiogenesis in vitro. Tissue Eng 2005;11:768-77.
12. Peltola MJ, Aitasalo KMJ, Suonpää JTK, Tli- Urpo A, Laippala PJ. In vivo model for frontal sinus and calvarian bone defect obliteration with bioactive glass S53P4 and hydroxyapatite. J Biomed Mater Res Appl Biomater 2001;58:261-9.
13. Paradowski PT, Bergman S, Sundén-Lundius A, Lomander LS, Roos EM., Knee complaints vary with age and gender in the adult population. Popular-based reference data for the Knee Injury and Osteoarthritis Outcome Score (KOOS). BMC Musculoscel Dis 2006;7:38.
14. Lindfors NC, Aho AJ. Granule size and composition of bioactive glass affect osteoconduction in rabbit. J Mater Sci: Mater Med 2003;14:365-372.
15. Lindfors NC. Treatment of a recurrent aneurysmal bone cyst with bioactive glass in a child allows for good remodelling and growth. Bone 2009;45:398-400.
16. Lindfors NC, Heikkilä JT, Koski I, Mattila K, Aho A., Bioactive glass and autogenous bone as bone graft substitutes in benign bone tumors. J Biomed Mater Res Appl Biomater 2009;90:131-6.
17. Lindfors NC, Koski I, Heikkilä JH, Mattila K, Aho AJ., A prospective randomized 14-year follow-up study of bioactive glass and autogenous bone as bone graft substitutes in benign bone tumors. J Biomed Mater Res Appl Biomater 2010;94:157-164.
18. Roos E, Roos H, Lohmander S, Ekdahl C, Beynnon B., Knee injury and osteoarthritis outcome score (KOOS)-development of a self-administered outcome measure. J Orthop Sports Phys Ter 1998;28:88-96.
19. Honkonen SE. Degenerative arthritis after tibial plateau fractures. J Orthop Trauma 1995;9:273-277.
20. Honkonen SE. Indications for surgical treatment of tibial condyle fractures. Clin Orthop Rel Res 1994;302:199-205.
21. Volpin G, Dowd GS, Stein NNN. Degenerative arthritis after intra-articular fractures of the knee. Long-term results. JBJS 1990;72:634-8.
22. Trenholm A, Landry S, McLaughlin K, Deluzio K, Leighton J, Trask K, Leighton R., Comparative fixation of tibial plateau fractures using (alpha)-BSM, a calcium phosphate cement, versus cancellous bone graft. J Orthop Trauma 2005;19:698-702.
23. Russell TA, Leighton RK. Comparison of autogenous bone graft and endothermic calcium phosphate cement for defect augmentation in tibial plateau fractures. JBJS 2008;90-A: 2057-61.
24. Jubel A, Andermahr J, Mairhofer J, Prokop A, Hahn U, Rehm KE., Die anwendung des injizierbaren knochenzement Norian SRS bei tibiakopffrakture. Orthopäde 2004;8:919-27.
25. Kwiatowski K, Cemer W, Sowinski T. Frozen allogenic spongy bone grafts in filling the defects caused by fractures of proximal tibia. Annals Trans 1999;3-4:49-51.
26. Boraiah S, Paul O, Hawkes D, Wickham M, Lorich DG., Complications of recombinant human BMP-2 for treating complex tibial plateau fractures. Clin Orthop Rel Res 2009;467: 3257-62.
27. Greenspan A, Remagen W. Differential diagnosis of tumors and tumor-like lesions of bones and joints. Lippincot-Raven publishers, PA, USA, 1998, 8.